Federica Galimberti
Federica Galimberti publishes mostly in Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism, on topics such as Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins and Pharmaceutical Practices and Patient Outcomes.
- World rank
- #905,194 of 7,710,434 ranked researchers
- Rank in Italy
- #27,903 of 242,206
- Works
- 77
- Citations
- 965
- Citations per work
- 12.5
What does Federica Galimberti research?
Federica Galimberti's work is mostly in Medicine (57%), Economics, Econometrics and Finance (6%), Biochemistry, Genetics and Molecular Biology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4456.6%
- Medicine4456.6%
- Everything else2532.7%
- Social Sciences45.6%
- Life Sciences45.1%
- 1Surgery26% of their works
- 2Cardiology and Cardiovascular Medicine15% of their works
- 3Endocrinology, Diabetes and Metabolism9% of their works
- 4Geriatrics and Gerontology7% of their works
- 5Economics and Econometrics6% of their works
- 6Cancer Research5% of their works
Research topics
- Lipoproteins and Cardiovascular Health
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Pharmaceutical Practices and Patient Outcomes
- Cancer, Lipids, and Metabolism
- Lipid metabolism and disorders
- Health Systems, Economic Evaluations, Quality of Life
- Medication Adherence and Compliance
- Cholesterol and Lipid Metabolism
Which keywords describe Federica Galimberti's research?
The keywords of their largest research topics: Statins, Cardiovascular Disease Prevention, Cholesterol-lowering, LDL Cholesterol, Atherosclerosis, Cholesterol, Metabolic Syndrome and Cardiovascular Disease.
- Metabolism
- LXR
- Lipoprotein Lipase
- Fatty Acid Synthase
- ANGPTL3
- Inappropriate Medication Use
- Cardiovascular Disease
- Cholesterol
- LDL Cholesterol
- Cardiovascular Disease Prevention
- Statins
- Cholesterol-lowering
- Atherosclerosis
- Metabolic Syndrome
- Diabetes
- Polypharmacy
- Cost-effectiveness Analysis
- Lipid Metabolism
- Quality of Life
- Medication Adherence
- Treatment Adherence
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 21 words, with their numbers
- Statins482 topics
- Cardiovascular Disease Prevention472 topics
- Cholesterol-lowering391 topic
- LDL Cholesterol391 topic
- Atherosclerosis313 topics
- Cholesterol313 topics
- Metabolic Syndrome232 topics
- Cardiovascular Disease141 topic
- Diabetes141 topic
- Inappropriate Medication Use141 topic
- Polypharmacy141 topic
- ANGPTL391 topic
- Cost-effectiveness Analysis91 topic
- Fatty Acid Synthase91 topic
- Lipid Metabolism91 topic
- Lipoprotein Lipase91 topic
- Quality of Life91 topic
- LXR81 topic
- Medication Adherence81 topic
- Metabolism81 topic
- Treatment Adherence81 topic
Where does Federica Galimberti work?
Federica Galimberti's main affiliation in the publication record is MultiMedica, Italy.
How many publications and citations does Federica Galimberti have?
OpenAlex counts 77 works and 965 citations for Federica Galimberti, an h-index of 16, ranking #905,194 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Federica Galimberti. Posts are plain text and can be reported.